SG11201505517TA - Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands - Google Patents
Use of selective delta-opioid receptor antagonists and specific sensory receptor ligandsInfo
- Publication number
- SG11201505517TA SG11201505517TA SG11201505517TA SG11201505517TA SG11201505517TA SG 11201505517T A SG11201505517T A SG 11201505517TA SG 11201505517T A SG11201505517T A SG 11201505517TA SG 11201505517T A SG11201505517T A SG 11201505517TA SG 11201505517T A SG11201505517T A SG 11201505517TA
- Authority
- SG
- Singapore
- Prior art keywords
- specific sensory
- selective delta
- receptor antagonists
- opioid receptor
- receptor ligands
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361754756P | 2013-01-21 | 2013-01-21 | |
PCT/SG2014/000025 WO2014112955A1 (en) | 2013-01-21 | 2014-01-21 | Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201505517TA true SG11201505517TA (en) | 2015-09-29 |
Family
ID=51209923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201505517TA SG11201505517TA (en) | 2013-01-21 | 2014-01-21 | Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands |
Country Status (5)
Country | Link |
---|---|
US (1) | US20150352100A1 (en) |
EP (1) | EP2945627A4 (en) |
CN (1) | CN105101964A (en) |
SG (1) | SG11201505517TA (en) |
WO (1) | WO2014112955A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017039778A1 (en) * | 2015-08-31 | 2017-03-09 | Regents Of The University Of Minnesota | Opioid receptor modulators and use thereof |
US20230405075A1 (en) | 2020-07-08 | 2023-12-21 | Herba Invest, Pte. Ltd. | Preparations containing mitragyne extract or its isolated alkaloids and cannabis extract or its isolated cannabinoids, and cosmetic and/or pharmaceutical use thereof |
EP4274546A1 (en) * | 2021-01-06 | 2023-11-15 | The Penn State Research Foundation | Methods and materials for treating hair loss |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266574A (en) * | 1984-04-09 | 1993-11-30 | Ian S. Zagon | Growth regulation and related applications of opioid antagonists |
SE9304236D0 (en) * | 1993-12-22 | 1993-12-22 | Astra Ab | New use |
US20080045610A1 (en) * | 2004-09-23 | 2008-02-21 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
US20090233841A1 (en) * | 2005-01-05 | 2009-09-17 | Regents Of The University Of Minnesota | Analgesic conjugates |
KR20080046677A (en) * | 2005-09-23 | 2008-05-27 | 디에스엠 아이피 어셋츠 비.브이. | Use of opioid receptor antagonists |
US7939567B2 (en) * | 2006-02-24 | 2011-05-10 | Blue Blood Biotech Corp. | Dextromethorphan-based method for treating acne |
CN101432011A (en) * | 2006-02-27 | 2009-05-13 | 亚历山大·米哈洛 | Methods for regulating neurotransmitter systems by inducing counteradaptations |
WO2007100775A2 (en) * | 2006-02-27 | 2007-09-07 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
WO2009012376A1 (en) * | 2007-07-17 | 2009-01-22 | The Ohio State University Research Foundation | Compositions and methods for skin care |
US20120114706A1 (en) * | 2008-05-08 | 2012-05-10 | Dipak Kumar Sarkar | Endorphin Therapy Compositions and Methods of Use Thereof |
WO2009138734A2 (en) * | 2008-05-14 | 2009-11-19 | Serentis Limited | Use of opioid compounds in peripheral pain, wound healing and scar formation |
US9283175B2 (en) * | 2011-07-28 | 2016-03-15 | Ian S. Zagon | Methods and compositions for treatment of epithelial wounds |
-
2014
- 2014-01-21 WO PCT/SG2014/000025 patent/WO2014112955A1/en active Application Filing
- 2014-01-21 SG SG11201505517TA patent/SG11201505517TA/en unknown
- 2014-01-21 CN CN201480005457.XA patent/CN105101964A/en active Pending
- 2014-01-21 US US14/762,046 patent/US20150352100A1/en not_active Abandoned
- 2014-01-21 EP EP14740942.9A patent/EP2945627A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2945627A4 (en) | 2016-11-30 |
EP2945627A1 (en) | 2015-11-25 |
WO2014112955A1 (en) | 2014-07-24 |
CN105101964A (en) | 2015-11-25 |
US20150352100A1 (en) | 2015-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2200048I1 (en) | Fcrn antagonists and methods of use | |
IL254569A0 (en) | St2l antagonists and methods of use | |
HK1220373A1 (en) | Il-33 antagonists and uses thereof il-33 | |
ZA201505705B (en) | Phi-4 polypeptides and methods for their use | |
IL246221A0 (en) | Indazoles and use thereof | |
IL240275B (en) | Selective antisense compounds and uses thereof | |
EP2958596A4 (en) | Psma ligands and uses thereof | |
GB201305668D0 (en) | Avs6 Integrin Antagonists | |
IL240820A0 (en) | Androgen receptor down-regulating agents and use thereof | |
HK1214333A1 (en) | Bracket and use | |
IL245977A0 (en) | Gabapentinoids and sigma receptor ligands combinations | |
SG11201602579SA (en) | Bicyclic alkyne derivatives and uses thereof | |
IL243433B (en) | Tib2 layres and use thereof | |
HK1224302A1 (en) | Novel anti-fc-gamma receptor iib antibodies and uses thereof -fc- iib | |
SG11201601245VA (en) | Plating apparatus and sensing device using same | |
SG11201505517TA (en) | Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands | |
GB201300403D0 (en) | Flow sensors and apparatus | |
EP2971131A4 (en) | Methods and materials using signaling probes | |
TWM475961U (en) | Sensory integration stimulation device | |
EP2986627A4 (en) | INHIBITORS OF THE Eph-A RECEPTOR AND USES THEREOF | |
GB201307049D0 (en) | Catalysts and use thereof | |
IL242818B (en) | Il-1beta-il-1ra chimera and methods of using the same | |
GB201311940D0 (en) | Characterising Polypeptides | |
GB201302677D0 (en) | Person and fluid sensor |